September marked the 23rd Annual Discovery on Target (DOT), showcasing the latest in novel drug targets, emerging drug modalities and innovative technologies. Over the years DOT has turned into a meeting place for the very latest in early drug discovery, bringing together scientists from academia, start-ups, biotechs, pharma and investing companies. With nearly 1000 attendees, 220+ presentations, 115+ research posters and ~90 exhibitors, DOT covered everything...